MORGAN STANLEY - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$202,972
+102.5%
203,000
+97.1%
0.00%
Q4 2022$100,250
+1153.1%
103,000
+1187.5%
0.00%
Q3 2022$8,0000.0%8,0000.0%0.00%
Q2 2022$8,0000.0%8,0000.0%0.00%
Q1 2022$8,0000.0%8,0000.0%0.00%
Q4 2021$8,000
-50.0%
8,000
-50.0%
0.00%
Q3 2021$16,000
-70.9%
16,000
-71.4%
0.00%
Q2 2021$55,000
+1.9%
56,0000.0%0.00%
Q1 2021$54,0000.0%56,0000.0%0.00%
Q4 2020$54,000
+5.9%
56,0000.0%0.00%
Q3 2020$51,000
+628.6%
56,000
+600.0%
0.00%
Q2 2020$7,0008,0000.00%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders